MIND Diet for Breast Cancer
(MIND-BC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates whether the MIND diet can help breast cancer survivors improve cognitive function, which cancer treatment can affect. Participants will either follow the MIND diet, known for its brain health benefits, or continue their usual diet. The trial aims to determine if the MIND diet can make a positive difference over a 12-week period, with additional follow-up. Individuals who have had stage I-III breast cancer, completed treatment 6 months to 3 years ago, and experience cognitive impairment related to their cancer may be suitable for this study. As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could enhance cognitive health for breast cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the MIND diet is safe for breast cancer survivors?
Research has shown that the MIND diet is generally easy for most people to follow. Studies have found that those who adhere closely to the MIND diet often experience positive health benefits. In one study, 65% of participants reported good results. Importantly, no serious side effects have been reported from following this diet.
The MIND diet emphasizes foods that support brain health, such as leafy greens, berries, and nuts. Some individuals might notice minor digestive changes when starting the diet, but these are usually temporary and not harmful. Overall, the diet is considered safe for most people, including breast cancer survivors.12345Why are researchers excited about this trial?
Researchers are excited about the MIND diet for breast cancer because it offers a fresh approach by focusing on dietary patterns rather than traditional medical treatments like chemotherapy, radiation, or hormone therapy. Unlike standard treatments, which can have significant side effects, the MIND diet emphasizes brain-healthy foods like berries and leafy greens, potentially enhancing overall well-being without harsh side effects. Additionally, this diet could empower patients by giving them an active role in their treatment through lifestyle changes, which is a shift from more passive, treatment-focused approaches.
What evidence suggests that the MIND diet might be an effective treatment for breast cancer-related cognitive impairment?
Research has shown that following the MIND diet may slow memory and thinking problems. Studies have found that this diet could help prevent these issues, particularly in women. Those who closely adhere to the MIND diet tend to experience better health outcomes. In this trial, participants in the MIND Diet Arm will follow the MIND diet, which studies have linked to improved brain function in postmenopausal breast cancer survivors. While not all studies show strong effects, most report positive results. This suggests that the MIND diet might effectively improve brain health in breast cancer survivors.23456
Who Is on the Research Team?
Sylvia Crowder
Principal Investigator
Moffitt Cancer Center
Are You a Good Fit for This Trial?
The MIND-BC Study is for breast cancer survivors who have finished their adjuvant treatment between 6 months and 3 years ago, are experiencing chronic cognitive impairment, and have a low MIND diet score (less than 8), indicating a diet not optimal for brain health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants follow the MIND diet with weekly check-ins with a diet coach
Maintenance
Participants continue the MIND diet to evaluate longer-term effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- MIND Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator